记者丨黎雨桐 见习记者林健民 6日，A股三大指数高开，截至9：50左右，沪指报4054.25点，突破2025年11月14日的阶段高点，刷新 2015年7月底以来的新高。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ | 上证指数 深证成指 | 科创综指 | | --- | --- | | 4054.25 13946.42 | 1723.70 | | +30.83 +0.77% +117.79 +0.85% +27.86 +1.64% | | | 创业板指 万得全A | 北证50 | | 6599.79 3318.62 | 1482.88 | | +61.85 +0.95% +24.07 +0.73% +16.46 +1.12% | | | 沪深300 中证500 | 中证A500 | | 4762.71 7745.80 | 5823.89 | | +44.97 +0.95% +94.61 +1.24% +60.59 +1.05% | | | 中证1000 深证100 | 中证红利 | | 7818.17 5966.20 | 5538.87 | | +64.29 +0.83% +37 ...

Market Overview - The market opened strongly, with the ChiNext Index leading the gains, and the Shanghai Composite Index returning above 4000 points, recording twelve consecutive days of gains. The total trading volume in the Shanghai and Shenzhen markets reached 2.55 trillion, an increase of 501.1 billion compared to the previous trading day. The Shanghai Composite Index rose by 1.38%, the Shenzhen Component Index by 2.24%, and the ChiNext Index by 2.85% [1]. Industry Insights - CITIC Securities highlighted that the nuclear fusion sector is entering a period of intensive catalytic release, with significant technological advancements expected to drive a synchronized market trend between domestic and international markets early next year. The long-term growth trend of the industry has been established, with domestic capital expenditure progressing steadily and overseas developments likely to exceed expectations [2]. - Open Source Securities noted that gaming could serve as a significant application scenario for brain-computer interfaces (BCIs) and AI. The recent launch of China's first fully implanted, wireless BCI product by Shanghai Brain Tiger Technology marks a critical breakthrough in core BCI technology, enabling previously disabled individuals to engage in gaming through brain control. Elon Musk's Neuralink plans to mass-produce BCI chips by 2026, with a streamlined and automated implantation process expected to accelerate the maturity of various application scenarios, including gaming and medical rehabilitation [3]. - CITIC Construction Investment pointed out that the AI medical sector is expected to see continuous progress in policy, technology, products, and applications by 2025. The application of AI in healthcare is anticipated to expand from large hospitals to grassroots and individual levels, enhancing medical device functionality, interpreting test results, assisting clinical decision-making, and health management. The ongoing support from national policies and industry technologies is likely to accelerate the implementation of AI medical applications, presenting investment opportunities in the sector [4].

Core Viewpoint - Qinghai Province is implementing collaborative reforms in healthcare, medical insurance, and pharmaceuticals to enhance the healthcare experience for its residents, aiming for a more integrated and efficient system [1][2][8] Group 1: Collaborative Development of Healthcare, Medical Insurance, and Pharmaceuticals - The provincial government has established a unified leadership mechanism for "three medical" work, breaking down barriers between healthcare, medical insurance, and pharmaceuticals [2] - Over 100 policy measures have been introduced since the start of the 14th Five-Year Plan to support the comprehensive reform of the healthcare system [2] - The collaborative mechanism has been effectively explored at the grassroots level, with initiatives like the "three medical" coordination meetings improving policy integration [2] Group 2: Hierarchical Diagnosis and Treatment - Qinghai has established 46 tightly-knit county medical communities, covering 62 county hospitals and 389 grassroots medical institutions, with inpatient and treatment volume ratios reaching 54.02% and 45.66% respectively [3] - The establishment of provincial medical centers in various cities has improved access to healthcare, allowing residents to receive treatment closer to home [3] - 65.91% of township health centers and community health service centers meet national service capacity standards, enhancing the quality of care at the grassroots level [3] Group 3: Medical Insurance Reform - Qinghai has achieved provincial-level coordination of urban and rural residents' medical insurance, with 5.4616 million people insured, exceeding targets [5] - The province has implemented a comprehensive medical security system, with significant reductions in average medical costs and hospital stay durations [5] - The introduction of "smart medical insurance" initiatives has improved accessibility and efficiency in medical billing and insurance claims [5] Group 4: Pharmaceutical Supply and Accessibility - Qinghai has reduced drug prices through centralized procurement and established a unified drug directory for medical communities, ensuring a wide range of medications are available [7] - The province has achieved a high quality assurance rate for drugs, with a 99.65% pass rate in quality inspections [7] - The integration of traditional Tibetan medicine into the healthcare system has been emphasized, with a significant number of traditional medicines included in the insurance coverage [6][7] Group 5: Ongoing Challenges and Future Directions - Despite notable achievements, challenges remain in the collaborative mechanism, data sharing, and the sustainability of medical insurance funds [8] - The provincial government plans to focus on key areas such as public hospital reform, medical insurance system reform, and strengthening the pharmaceutical supply chain to further enhance the "three medical" collaborative development [8] - The ongoing reforms aim to make healthcare more accessible, affordable, and supportive for the diverse population in Qinghai [8]

证券研究报告|宏观研究报告 [Table_Date] 2026 年 01 月 05 日 PPI呈现"上半年磨底、三季度分化、10-11月温和回升"的修复路 径。8 月是"反内卷"政策落地之后，PPI 的关键分水岭。分行业来看，绝 大多数高权重行业均陷入负值区间，仅有色金属链条形成唯一的正向支 撑。究其原因，内需不足与"内卷式"竞争形成"双重压制"，PPI 的下行压 力主要源于以下两类核心行业：第一类是高权重的中游制造行业，主要 受"内卷"竞争拖累。第二类是上游资源与原材料行业，受地产基建需求 疲软与国际油价回落的共振拖累。 ► 2026 年 CPI 展望：猪周期有望企稳，通胀中枢温和抬升 在 2026 年基期轮换中，猪肉权重有望上升，金银珠宝权重或下 降。回顾 2016 年与 2020 年两次基期轮换，均呈现"食品降、服务升"的 特征，主要遵循"消费升级"主线。2026 年权重调整逻辑或发生逆转：其 一，地产供需格局重塑，居住项权重面临下调（预计-3.0pct）。其二， 疫后修复弹性释放，服务类消费权重显著抬升（预计文娱+2.2pct，交 通+1.4pct）。其三，恩格尔系数回归下行通道，食品烟酒权重延续调降 ...

Core Viewpoint - The A-share and Hong Kong stock markets experienced significant gains at the beginning of 2026, indicating a positive market sentiment and potential investment opportunities [1][17]. Group 1: Market Performance - The A-share market overall rose, achieving a rating around 4.0 stars, with all market caps (large, medium, and small) showing upward movement [2][3]. - Growth style stocks saw a more substantial increase compared to value style stocks, which experienced slight gains [4]. - The Hong Kong stock market, including indices like the Hang Seng Index and Hang Seng Tech Index, also rose, returning to normal valuation levels [5][11]. Group 2: Valuation Trends - As the markets rose, the green rate of the valuation table gradually decreased, indicating a shift in market sentiment [6]. - The AH share premium index, which measures the price difference between A-shares and H-shares of the same companies, has fluctuated between 120-140 in recent years, suggesting that A-shares are typically priced higher due to various costs associated with H-shares [27][28]. Group 3: Future Outlook - The recovery in A-share company earnings is expected to continue, with a slight decline in 2024 followed by a recovery in 2025, which could positively impact both A-shares and Hong Kong stocks [40][41]. - The anticipated continuation of the US Federal Reserve's interest rate cuts and the recovery of A-share earnings could further support the upward trend in both markets [43]. Group 4: Investment Strategies - The article emphasizes a strategy of buying during market dips and selling during peaks, while maintaining patience during stable periods [45]. - The importance of continuous learning and reading in investment practices is highlighted, suggesting that knowledge can translate into better investment decisions [54].

Group 1 - The A-share medical sector experienced a significant rally on January 5, 2026, led by the brain-computer interface concept, with key stocks like Sanbo Brain Science, Meihao Medical, and Lepu Medical hitting the 20% daily limit up [1] - The largest medical ETF in the market, tracking the medical index, surged by 5.29% to reach its highest point since October 9, 2024, with a trading volume of 1.166 billion yuan, an increase of over 211% compared to the previous trading day [1] - In the Hong Kong market, the medical sector also performed strongly, particularly in innovative drugs, with the Hong Kong Innovation Drug ETF rising by 5.42%, marking its largest single-day increase since its launch in July 2025 [2] Group 2 - Elon Musk announced on social media that his brain-computer interface company, Neuralink, will begin mass production of brain-computer interface devices in 2026, indicating a significant advancement in the technology [3] - According to CITIC Securities, China's research in brain-computer interface technology is relatively advanced globally, which is expected to enhance the valuations of related listed companies and stimulate financing in the primary market [3] - The National Medical Products Administration reported that 76 innovative drugs were approved for market in 2025, setting a historical record, with total licensing transactions exceeding $130 billion [5] Group 3 - The Hong Kong medical sector saw a collective rise in various concepts, including brain-computer interfaces and internet healthcare, with stocks like Microneuro Science and Brain Dynamics-B increasing by 19.73% and 15.74%, respectively [5] - The upcoming listing of the Hong Kong medical ETF Huabao (159137) is anticipated to attract attention, as it tracks the medical theme index [5] - Long-term strategies in the medical sector remain focused on innovation, with expectations for strong performance in 2026, particularly in innovative medical devices and drugs [5]

资金流向方面，创业板医疗（970082）指数成份股当日主力资金净流入合计12.33亿元，游资资金净流 出合计8.49亿元，散户资金净流出合计3.84亿元。成份股资金流向详情见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，1月5日，创业板医疗（970082）指数报收于3808.57点，涨5.7%，成交202.09亿元，换 手率2.83%。当日该指数成份股中，上涨的有48家，三博脑科以20.01%的涨幅领涨，下跌的有2家，华 兰股份以3.23%的跌幅领跌。 创业板医疗（970082）指数十大成份股详情如下： ...

Group 1 - The core point of the article is that JinHao Medical (stock code: 920925) experienced a significant price increase of 20.03% on January 5, 2026, leading to its appearance on the stock market's "Dragon and Tiger List" [1][3] - The trading volume for JinHao Medical on that day reached 10.8265 million shares, with a total transaction value of 394 million yuan [1][2] - The top buying position was held by Huatai Securities Co., Ltd. with a purchase amount of approximately 13.12 million yuan, while the top selling position was held by Debon Securities Co., Ltd. with a selling amount of approximately 15.54 million yuan [1][2] Group 2 - The article provides detailed trading data, including the top five buying and selling brokerage firms, highlighting significant transactions from various securities companies [2] - Notably, the second-largest buying position was from China Galaxy Securities with approximately 11.51 million yuan, and the third from Dongfang Securities with about 10.48 million yuan [2] - On the selling side, the second-largest selling position was from Guosen Securities with approximately 15.24 million yuan, indicating a competitive trading environment [2]

中新社北京1月5日电 (记者 陈康亮)在2026年的首个交易日，中国A股收获"开门红"，主要股指悉数飘 红；其中，上证指数当天基本呈高开高走之势，突破4000点整数关口。 截至5日收盘，上证指数报4023点，涨幅为1.38%；深证成指报13828点，涨幅为2.24%；创业板指报 3294点，涨2.85%。沪深两市成交总额约25463亿元(人民币，下同)，较上一个交易日放量约5011亿元。 消息面上，美国企业家埃隆·马斯克近日在社交媒体上表示，其脑机接口公司"神经连接"将于2026年开 始对脑机接口设备进行"大规模生产"，并转向"更加精简和几乎完全自动化的外科手术流程"。(完) 华西证券分析师李立峰表示，A股"春季躁动"行情已提前开启。从宏观政策来看，2026年是"十五五"开 局之年，多部门有望出台更多产业支持政策和投资规划，财政、货币政策也将协同发力，这些都将为市 场营造友好环境；从产业周期来看，随着中国工业生产者出厂价格指数(PPI)表现向好，预计2026年企 业盈利将进入温和复苏通道。综合来看，2026年是多个正面因素叠加的"大年"，市场向上基础扎实。 板块方面，当天A股大多数板块收涨。根据金融数据服务商 ...

民生无小事，枝叶总关情。发展的成果，就写在热气腾腾的生活里。 2025年，武汉首试"票决制"，市民提、代表定、政府办，十大类38项民生实事当年落地。从"一老一 小"到"安居畅行"，一桩桩一件件回应着最普通的期盼。 一年已尽，变化看得见。古田一路通车，王老先生送学不再绕路；老楼新装电梯，陈奶奶眼里有光；孤 独症孩子轩轩开口分享时，妈妈眉头舒展。这些瞬间的笑容拼出一座"暖城"最真实的模样。 路，在脚下顺了 血脉畅通，城市才有活力，生活才有奔头。 "以前开车送孙子上学，绕三环线得花近半小时；现在走古田一路高架桥，3分钟就到了。"2025年12月 28日，古田一路北段通车，家住硚口区古田街道古田社区的王老先生言语中满是畅快。这条跨越8条铁 路线的交通大动脉不仅打通了武汉西部交通的"任督二脉"，更让沿线22万名居民的生活"快了一步"。 古田一路高架桥的建设是2025年被"投"出来的武汉交通民生实事标志性项目。这一年，十大类38项民生 实事迅速落地。 在武昌区积玉桥街道，一条长800米的微循环路刚完成改造，原本狭窄拥堵的街巷变得宽敞整洁，增设 的人行道护栏和照明设施让居民出行更安心。"这条路以前错车都难，现在遛弯、买菜都 ...